In the latest of a flurry of announcements ahead of the holiday period, CMS has revealed a new, voluntary access programme that aims to broaden the use of GLP-1 agonist medicines for diabetes and ...

In the latest of a flurry of announcements ahead of the holiday period, CMS has revealed a new, voluntary access programme ...

The French pharma major has started a $15.50 per share cash tender offer for Emeryville, California-based Dynavax, which ...

In labs, water consumption and single-use plastics like pipette tips can contribute to environmental impact. Lab equipment ...

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Tarek Samad, Lundbeck’s senior vice president and head ...

The Centers for Medicare & Medicaid Services (CMS) has proposed two more programmes in the Trump administration's efforts to ...

People in life sciences companies understand how patents are crucial to their business, by setting competitive boundaries, ...

The FDA has delivered a gift to Novo Nordisk ahead of the holiday season, with the prompt approval of an oral formulation of ...

But the digital-first promise carried a blind spot: it solves for tasks, not emotions. Patients don’t start, stay on, or ...

Months of uncertainty have come to a close. The BIOSECURE Act, now part of the National Defense Authorization Act (NDAA), will put in motion US government-wide restrictions on ‘biotechnology companies ...

Dermot Kenny, who leads STEM and Research Partnership within Inizio Advisory, shares his journey from bench scientist to CEO, his personal motivations rooted in patient impact, and his perspective on ...

Regulators in the UK and US are the first to approve GSK's Exdensur, a long-acting, twice-yearly IL-5 inhibitor for severe asthma that has been billed as a major new product for the drugmaker. In the ...